These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 5369675)

  • 1. Immunotherapy and chemotherapy of Moloney sarcoma virus-induced tumors in mice.
    Fefer A
    Cancer Res; 1969 Dec; 29(12):2177-83. PubMed ID: 5369675
    [No Abstract]   [Full Text] [Related]  

  • 2. Protective effect of immune sera against transplantable Moloney virus-induced sarcoma and lymphoma.
    Pearson GR; Redmon LW; Bass LR
    Cancer Res; 1973 Jan; 33(1):171-8. PubMed ID: 4734119
    [No Abstract]   [Full Text] [Related]  

  • 3. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors.
    Collavo D; Ronchese F; Zanovello P; Biasi G; Chieco-Bianchi L
    J Immunol; 1982 Feb; 128(2):774-9. PubMed ID: 6459385
    [No Abstract]   [Full Text] [Related]  

  • 4. Serochemotherapy against a Moloney virus-induced leukemia.
    Pearson GR; Redmon LW; Pearson JW
    Cancer Res; 1973 Aug; 33(8):1854-7. PubMed ID: 4578564
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined immunotherapy and chemotherapy of Moloney sarcoma virus-induced tumors in mice.
    Giuliani F; Casazza AM; Di Marco A
    Biomedicine; 1973 Sep; 18(5):387-92. PubMed ID: 4752705
    [No Abstract]   [Full Text] [Related]  

  • 6. An immunochemotherapeutic system for the treatment of a transplanted Moloney virus-induced lymphoma in mice.
    Glynn JP; Halpern BL; Fefer A
    Cancer Res; 1969 Mar; 29(3):515-20. PubMed ID: 4180092
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunologic, virologic, and pathologic studies of regression of autochthonous Moloney sarcoma virus-induced tumors in mice.
    Fefer A; McCoy JL; Perk K; Glynn JP
    Cancer Res; 1968 Aug; 28(8):1577-85. PubMed ID: 4876979
    [No Abstract]   [Full Text] [Related]  

  • 8. Factors related to therapeutic efficacy in adoptive chemoimmunotherapy of a Friend virus-induced lymphoma.
    Fass L; Fefer A
    Cancer Res; 1972 Nov; 32(11):2427-31. PubMed ID: 5082591
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunization with p30 enhances the growth of a rat Moloney sarcoma.
    Jones JM; Kennel SJ; Feldman JD
    J Immunol; 1977 Jan; 118(1):371-3. PubMed ID: 830759
    [No Abstract]   [Full Text] [Related]  

  • 10. [Possible use of Moloney virus to increase the resistance of Balb-c mice to transplantation of methylcholanthrene induced sarcoma].
    Fedorovs'ka MI; Verkhats'kiĭ PP; Vetkova OP; Kamins'ka LP; Umans'kiĭ IuO
    Mikrobiol Zh; 1972; 34(1):59-60. PubMed ID: 5077265
    [No Abstract]   [Full Text] [Related]  

  • 11. Adoptive tumor immunotherapy in mice as an adjunct to whole-body x-irradiation and chemotherapy. A review.
    Fefer A
    Isr J Med Sci; 1973 Mar; 9(3):350-65. PubMed ID: 4145461
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunological and pathological manifestations of murine sarcoma virus (Moloney) infections.
    Schlom J; Moloney JB; Groupé V
    Cancer Res; 1970 Dec; 30(12):2955-61. PubMed ID: 5494580
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on immunity to autochthonous mouse tumors.
    Hellström I; Hellström KE; Pierce GE; Fefer A
    Transplant Proc; 1969 Mar; 1(1):90-4. PubMed ID: 5406848
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunotherapy of primary Moloney sarcoma-virus-induced tumors.
    Fefer A
    Int J Cancer; 1970 May; 5(3):327-37. PubMed ID: 5452066
    [No Abstract]   [Full Text] [Related]  

  • 15. Reversal by thymosin of increased susceptibility of immunosuppressed mice to Moloney sarcoma virus.
    Hardy MA; Zisblatt M; Levine N; Goldstein AL; Lilly F; White A
    Transplant Proc; 1971 Mar; 3(1):926-8. PubMed ID: 5095897
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibitory effects of xenogeneic antiserum on the growth of Moloney virus-induced sarcomas.
    Pierce GE
    J Surg Oncol; 1977; 9(3):249-56. PubMed ID: 875394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing effect on tumour growth of humoral antibodies against tumour specific transplantation antigens in tumours induced by murine sarcoma virus(Harvey).
    Bubenik J; Turano A
    Nature; 1968 Nov; 220(5170):928-30. PubMed ID: 5722149
    [No Abstract]   [Full Text] [Related]  

  • 18. Modification of the response of autochthonous Moloney sarcoma virus-induced tumors to poly I:C by DEAE-dx 1 .
    Kende M; Glynn JP
    Chemotherapy; 1971; 16(5):281-93. PubMed ID: 5146951
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the suitability of 2 isologous tumor-host systems for chemotherapeutic studies].
    Horn KH; Siewert R; Madry I
    Arch Geschwulstforsch; 1967; 29(4):324-30. PubMed ID: 4298570
    [No Abstract]   [Full Text] [Related]  

  • 20. Some biologic, immunogenic, and morphologic effects in mice after infection with a murine sarcoma virus. I. Biologic and immunogenic studies.
    Law LW; Ting RC; Stanton MF
    J Natl Cancer Inst; 1968 May; 40(5):1101-12. PubMed ID: 5648135
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.